Retraction
Function of miR‑152 as tumor suppressor in oral squamous cell carcinoma cells by targeting c‑MET
Paper Information
Record ID:
34924
Author(s):
Journal:
Publication Date:
December 15, 2017
Retraction Date:
January 04, 2022
(3.9 years years ago)
Subjects:
Institutions:
- Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Jilin University, Changchun, Jilin 130021, P.R. China
- Department of Thoracic Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China
- Department of Dentistry, The General Hospital of FAW, Changchun, Jilin 1300000, P.R. China
- Department of Endodontics, Hospital of Stomatology, Jilin University, Changchun, Jilin 130021, P.R. China
- Department of Periodontology, Hospital of Stomatology, Jilin University, Changchun, Jilin 130021, P.R. China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Spandidos
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (11)
11
Total Citations4
Post-Retraction(36.4%)
7
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
3
After 2+ years
1142
Days since retraction (latest)
A Microfluidic Approach for Intracellular Delivery into Red Blood Cells: A Deeper Understanding of the Role of Chemical/Rheological Properties of the Cellular Suspension
Clara Bernardelli, Monica Piergiovanni, Elena Bianchi et al. (6 authors)
Annals of Biomedical Engineering
Open Access
Published: Feb 2025
1142 days after retraction
New evidence for miRNA testing in head and neck squamous cell cancer patients
Blanca Pilar Galindo Torres, Raquel Alcaraz, Patricia Saiz-Lopez et al. (7 authors)
Clinical & Translational Oncology
Published: Feb 2025
1129 days after retraction
The multifaceted anticancer potential of luteolin: involvement of NF-κB, AMPK/mTOR, PI3K/Akt, MAPK, and Wnt/β-catenin pathways
D.V. Singh, Gaurav Shukla
Inflammopharmacology
Published: Nov 2024
3 citations
3 citations
1045 days after retraction
A snapshot of miRNAs in oral squamous cell carcinoma: Difference between cancer cells and corresponding normal cells
Vahid Hosseini, Soheila Montazersaheb, Narges Hejazi et al. (6 authors)
Pathology - Research and Practice
Published: Jul 2023
2 citations
2 citations
571 days after retraction
MicroRNAs and Long Non-coding RNAs in c-Met-Regulated Cancers
Hong Zhan, Sheng Tu, Feng Zhang et al. (5 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Mar 2020
24 citations
24 citations
664 days before retraction
Crosstalk Mechanisms Between HGF/c-Met Axis and ncRNAs in Malignancy
Xin Liu, Ranran Sun, Jianan Chen et al. (9 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Jan 2020
17 citations
17 citations
705 days before retraction
<i>EPAS1</i> targeting by miR-152-3p in Paclitaxel-resistant Breast Cancer
Ying Song, Mo Zhang, Man Lu et al. (12 authors)
Journal of Cancer
Open Access
Published: Jan 2020
22 citations
22 citations
734 days before retraction
Curcumol inhibits the proliferation and metastasis of melanoma via the miR-152-3p/PI3K/AKT and ERK/NF-κB signaling pathways
Ning Ning, Sulai Liu, Xiehong Liu et al. (10 authors)
Journal of Cancer
Open Access
Published: Jan 2020
44 citations
44 citations
734 days before retraction
Chemoresistance Mediated by ceRNA Networks Associated With the PVT1 Locus
Olorunseun O. Ogunwobi, Adithya Kumar
Frontiers in Oncology
Open Access
Published: Aug 2019
31 citations
31 citations
861 days before retraction
lncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET/PI3K/AKT pathway
Zeyu Sun, Yuekui Jian, Huan-Ye Zhu et al. (4 authors)
Pathology - Research and Practice
Published: Dec 2018
71 citations
71 citations
1119 days before retraction
MiR-1 inhibits prostate cancer PC3 cells proliferation through the Akt/mTOR signaling pathway by binding to c-Met
Song Gao, Zhiying Zhao, Rong Wu et al. (6 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Nov 2018
25 citations
25 citations
1149 days before retraction
Quick Stats
Total Citations:
11
Years Since Retraction:
3.9 years
Open Access:
Yes
Last Checked:
Jul 24, 2025